Menu
Back to User profile » Dr Toshinaga Tsuji
Papers published by Dr Toshinaga Tsuji:
Change in Antidepressant Use After Initiation of ADHD Medication in Japanese Adults with Comorbid Depression: A Real-World Database Analysis
Sakai C, Tsuji T, Nakai T, Namba Y, Mishima H, Fujiwara M, Matsunaga H
Neuropsychiatric Disease and Treatment 2021, 17:3097-3108
Published Date: 11 October 2021
The Relationship Between Baseline Clinical Symptom Characteristics and Working Ability in Japanese Patients Treated for Major Depressive Disorder and Painful Physical Symptoms
Sugawara N, Yasui-Furukori N, Tsuji T, Hayashi S, Ajisawa Y, Ochiai T, Imagawa H, Shimoda K
Neuropsychiatric Disease and Treatment 2020, 16:3063-3070
Published Date: 11 December 2020
Relationship Between Pain Reduction and Improvement in Health-Related Quality of Life in Patients with Knee Pain Due to Osteoarthritis Receiving Duloxetine: Exploratory Post Hoc Analysis of a Japanese Phase 3 Randomized Study
Enomoto H, Fujikoshi S, Ogawa K, Tsuji T, Tanaka S
Journal of Pain Research 2020, 13:181-191
Published Date: 20 January 2020
The added burden of depression in patients with osteoarthritis in Japan
Tsuji T, Nakata K, Vietri J, Jaffe DH
ClinicoEconomics and Outcomes Research 2019, 11:411-421
Published Date: 20 June 2019
Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapy
Kuga A, Otsubo T, Tsuji T, Hayashi S, Imagawa H, Fujikoshi S, Escobar R
Neuropsychiatric Disease and Treatment 2019, 15:809-817
Published Date: 5 April 2019
Response to duloxetine in patients with knee pain due to osteoarthritis: an exploratory post hoc analysis of a Japanese Phase III randomized study
Itoh N, Tsuji T, Ishida M, Ochiai T, Konno S, Uchio Y
Journal of Pain Research 2018, 11:2603-2616
Published Date: 26 October 2018
Duloxetine in patients with diabetic peripheral neuropathic pain in Japan: a randomized, double-blind, noninferiority comparative study with pregabalin
Enomoto H, Yasuda H, Nishiyori A, Fujikoshi S, Furukawa M, Ishida M, Takahashi M, Tsuji T, Yoshikawa A, Alev L
Journal of Pain Research 2018, 11:1857-1868
Published Date: 13 September 2018
Safety and efficacy of duloxetine in Japanese patients with chronic knee pain due to osteoarthritis: an open-label, long-term, Phase III extension study
Uchio Y, Enomoto H, Ishida M, Tsuji T, Ochiai T, Konno S
Journal of Pain Research 2018, 11:1391-1403
Published Date: 31 July 2018
A randomized, double-blind, placebo-controlled Phase III trial of duloxetine in Japanese patients with knee pain due to osteoarthritis
Uchio Y, Enomoto H, Alev L, Kato Y, Ishihara H, Tsuji T, Ochiai T, Konno S
Journal of Pain Research 2018, 11:809-821
Published Date: 18 April 2018
Response to duloxetine in chronic low back pain: exploratory post hoc analysis of a Japanese Phase III randomized study
Tsuji T, Itoh N, Ishida M, Ochiai T, Konno S
Journal of Pain Research 2017, 10:2157-2168
Published Date: 4 September 2017
An observational study of duloxetine versus SSRI monotherapy in Japanese patients with major depressive disorder: subgroup analyses of treatment effectiveness for pain, depressive symptoms, and quality of life
Kuga A, Tsuji T, Hayashi S, Fujikoshi S, Tokuoka H, Yoshikawa A, Escobar R, Tanaka K, Azekawa T
Neuropsychiatric Disease and Treatment 2017, 13:2115-2124
Published Date: 4 August 2017
An observational study of duloxetine versus SSRI monotherapy for the treatment of painful physical symptoms in Japanese patients with major depressive disorder: primary analysis
Kuga A, Tsuji T, Hayashi S, Matsubara M, Fujikoshi S, Tokuoka H, Yoshikawa A, Escobar R, Tanaka K, Azekawa T
Neuropsychiatric Disease and Treatment 2017, 13:2105-2114
Published Date: 4 August 2017
Duloxetine 60 mg for chronic low back pain: post hoc responder analysis of double-blind, placebo-controlled trials
Alev L, Fujikoshi S, Yoshikawa A, Enomoto H, Ishida M, Tsuji T, Ogawa K, Konno S
Journal of Pain Research 2017, 10:1723-1731
Published Date: 24 July 2017
Assessment of direct analgesic effect of duloxetine for chronic low back pain: post hoc path analysis of double-blind, placebo-controlled studies
Enomoto H, Fujikoshi S, Funai J, Sasaki N, Ossipov MH, Tsuji T, Alev L, Ushida T
Journal of Pain Research 2017, 10:1357-1368
Published Date: 1 June 2017
Association between pain severity, depression severity, and use of health care services in Japan: results of a nationwide survey
Vietri J, Otsubo T, Montgomery W, Tsuji T, Harada E
Neuropsychiatric Disease and Treatment 2015, 11:675-683
Published Date: 13 March 2015
Efficacy comparison of duloxetine and SSRIs at doses approved in Japan
Harada E, Schacht A, Koyama T, Marangell LB, Tsuji T, Escobar R
Neuropsychiatric Disease and Treatment 2015, 11:115-123
Published Date: 12 January 2015